New Antimicrobial and Antitumor Agents from Pyridine-1,2,4-triazole-3-thione-hydrazone
Author Information
Author(s): Šermukšnytė Aida, Stasevych Maryna, Komarovska-Porokhnyavets Olena, Zvarych Viktor, Jakubauskienė Eglė, Kantminienė Kristina, Tumosienė Ingrida
Primary Institution: Kaunas University of Technology
Hypothesis
Can hybrid compounds combining antimicrobial and anticancer properties be synthesized and evaluated for effectiveness?
Conclusion
The study identified several compounds with significant antimicrobial and anticancer activities, particularly against MDA-MB-231 and U-87 cell lines.
Supporting Evidence
- Compounds 15, 16, and 21 showed significant cytotoxicity against MDA-MB-231 cells with IC50 values of 39.2 ± 1.7 μM.
- Compound 6 demonstrated high antifungal activity against Candida tenuis with an MIC of 0.9 µg/mL.
- Compound 16 exhibited a growth inhibition zone of 14.4 mm against Staphylococcus aureus.
Takeaway
Scientists created new medicines that can fight infections and cancer at the same time, and some of them worked really well in tests.
Methodology
The compounds were synthesized and tested for antimicrobial and anticancer activities using various assays, including MTT assays for cell viability.
Limitations
The study did not explore the long-term effects or potential side effects of the compounds in vivo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website